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ABSTRACT
Objective Investigated clinical effectiveness and cost- 
effectiveness of a person- centred intervention for informal 
carers/caregivers of stroke survivors.
Design Pragmatic cluster randomised controlled trial 
(cRCT) with economic and process evaluation.
Setting Clusters were services, from a UK voluntary 
sector specialist provider, delivering support primarily in 
the homes of stroke survivors and informal carers.
Participants Adult carers in participating clusters were 
referred to the study by cluster staff following initial 
support contact.
Interventions Intervention was the Carer Support Needs 
Assessment Tool for Stroke: a staff- facilitated, carer- 
led approach to help identify, prioritise and address the 
specific support needs of carers. It required at least 
one face- to- face support contact dedicated to carers, 
with reviews as required. Control was usual care, which 
included carer support (unstructured and variable).
Outcome measures Participants provided study entry 
and self- reported outcome data by postal questionnaires, 
3 and 6 months after first contact by cluster staff. Primary 
outcome: 3- month caregiver strain (Family Appraisal of 
Caregiving Questionnaire, FACQ). Secondary outcomes: 
FACQ subscales of caregiver distress and positive 
appraisals of caregiving, mood (Hospital Anxiety and 
Depression Scale) and satisfaction with stroke services 
(Pound). The economic evaluation included self- reported 
healthcare utilisation, intervention costs and EQ- 5D- 5L.
Randomisation and masking Clusters were recruited 
before randomisation to intervention or control, with 
stratification for size of service. Cluster staff could not be 
masked as training was required for participation. Carer 
research participants provided self- reported outcome data 
unaware of allocation; they consented to follow- up data 
collection only.
Results Between 1 February 2017 and 31 July 2018, 35 
randomised clusters (18 intervention; 17 control) recruited 
414 cRCT carers (208 intervention; 206 control). Study 
entry characteristics were well balanced. Primary outcome 
measure: intention- to- treat analysis for 84% retained 
participants (175 intervention; 174 control) found mean 
(SD) FACQ carer strain at 3 months to be 3.11 (0.87) 
in the control group compared with 3.03 (0.90) in the 
intervention group, adjusted mean difference of −0.04 
(95% CI −0.20 to 0.13). Secondary outcomes had similarly 
small differences and tight CIs. Sensitivity analyses 
suggested robust findings. Intervention fidelity was not 
achieved. Intervention- related group costs were marginally 
higher with no additional health benefit observed on EQ- 
5D- 5L. No adverse events were related to the intervention.
Conclusions The intervention was not fully implemented 
in this pragmatic trial. As delivered, it conferred no clinical 
benefits and is unlikely to be cost- effective compared with 
usual care from a stroke specialist provider organisation. 
It remains unclear how best to support carers of stroke 
survivors. To overcome the implementation challenges 
of person- centred care in carers’ research and service 
development, staff training and organisational support 
would need to be enhanced.
Trial registration number ISRCTN58414120.
INTRODUCTION
Informal carers, providing unpaid support 
to family and friends with long- term health 
conditions, make an invaluable societal and 
Strengths and limitations of this study
 ► We successfully conducted the first adequately 
powered cluster randomised controlled trial of an 
approach to support informal carers of stroke sur-
vivors, but may have benefited from a feasibility trial 
to maximise intervention fidelity.
 ► We collaborated closely with service providers and 
previous service users to pragmatically tailor the 
intervention for implementation, including a staff- 
training package.
 ► The demographic profile of the sample was as ex-
pected for carers of stroke survivors but the sample 
lacked ethnic diversity and we may have benefited 
from seeking data beyond 6 months after support 
had been initiated.
 ► We highlight the feasibility of robust research with 
this population and signpost to suggestions from our 
nested process evaluation for improved implemen-
tation of person- centred care.
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economic contribution. BMJ published the ‘unremitting 
burden on carers’ over 30 years ago,1 but sadly carers’ 
own support needs are still often overlooked and being 
a caregiver often adversely affects health and well- being.2
Although countries such as the UK now mandate for the 
identification of carers’ support needs through the 2014 
Care Act,3 less than one- third report receiving a statutory 
assessment.2 One possible approach for comprehensive 
support is the Carer Support Needs Assessment Tool 
(CSNAT) intervention.4 The CSNAT intervention has 
multiple components including a comprehensive assess-
ment tool integrated within a staged carer- led approach 
to individualised support. It was developed, implemented 
and tested in the context of palliative care with positive 
outcomes, including a significant reduction in caregiver 
strain as measured on the Family Appraisal of Care-
giving Questionnaire (FACQ).5–9 We hypothesised that 
this intervention had the potential to support informal 
carers of people with long- term health conditions such as 
stroke, that causes a greater range of disabilities than any 
other in the UK.10 Recent systematic reviews and trials of 
carers of stroke survivors have highlighted the absence of 
a robustly proven support intervention.11–15
In close collaboration with a study- specific carer advisory 
research group (see the Patient and public involvement 
section) and a UK stroke service provider organisation, 
we adapted the CSNAT intervention including a staff 
training and implementation package tailored to the 
provider organisation (see the Interventions and proce-
dures section, and figure 1, table 1 and online supple-
mental table S1). This partnership was facilitated by the 
former National Institute for Health Research Collabora-
tion for Leadership in Applied Health Research and Care 
Greater Manchester (NIHR CLAHRC GM, https://www. 
clahrc- gm. nihr. ac. uk/, now Applied Research Collabora-
tions). The aim of the Organising Support for Carers of 
Stroke Survivors (OSCARSS) study was to determine the 
clinical and cost- effectiveness of the CSNAT- Stroke inter-
vention for carers of stroke survivors, when compared 
with usual care. The primary hypothesis was that the 
adapted intervention would reduce caregiver strain 
when compared with usual care. Secondary hypotheses 
explored the impact on other aspects of the carer experi-
ence (eg, well- being and satisfaction with services), as well 
as its economic impact.
METHODS
Study design
OSCARSS was a longitudinal, pragmatic, national cluster 
randomised controlled trial (cRCT), underpinned by 
patient and public involvement from our study- specific 
carer advisory research group.16 Cluster randomisation 
was essential to avoid contamination. Clusters were drawn 
from services commissioned by the National Health 
Service (NHS) or local authorities, delivered by a UK 
voluntary sector stroke specialist organisation providing 
long- term support to stroke survivors and carers, including 
hospital and home visits. Eligible clusters were those with 
capacity for research participation and delivering support 
to carers in their own homes and a minimum of five new 
client (survivor or carer) referrals per month, based on 
historical service delivery records from a 9- month period 
before the study began.
This paper focuses on the RCT to explore the inter-
vention’s clinical and cost- effectiveness. OSCARSS also 
included a mixed- methods embedded process evaluation 
to help understand intervention implementation and 
workforce adoption, described in detail elsewhere.17
Ethics approvals were obtained (see Ethics approval 
section) and the lead author (EP) affirms that this manu-
script is an honest, accurate and transparent account of 
the study being reported. The study methods and design 
have been described in detail, with no major changes 
made to protocol.18
Figure 1 The adapted CSNAT- Stroke intervention as 
intended. CSNAT- Stroke, Carer Support Needs Assessment 
Tool for Stroke.
Table 1 Summary of key differences between intervention 
and usual care
Usual care CSNAT- Stroke intervention
Focus primarily on stroke 
survivor
Focus specifically on carer
No formal process with 
carers: varies across 
services
A standardised assessment and 
support process for carers
Support carer if present Make appointment to include 
carer
Usually see together with 
stroke survivor
Normalise seeing carer 
separately
If carer present: prompt 
question from practitioner 
about carer’s own needs
Carer- led assessment and 
prioritisation of needs using 
evidence- based assessment 
tool and staged person- centred 
approach
Review times vary Carer- specific action and review 
plan
CSNAT- Stroke, Carer Support Needs Assessment Tool for Stroke.
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Patient and public involvement
A study- specific Research User Group (RUG) of 10 indi-
viduals with experience of caring for a stroke survivor 
was set up in December 2015, at the planning stages 
of OSCARSS. Through regular meetings (2015–2019) 
and representation on the Trial Management Group, 
the priorities, experiences and preferences of the RUG 
informed development of the research questions and the 
design, analysis/interpretation and dissemination of all 
components of the OSCARSS Study. The RUG supported 
authorship of an easy access report on the results of this 
study that has been sent to study participants (Dissemina-
tion Declaration).
The RUG advised on participant recruitment and were 
central in limiting the burden of participation for carers. 
The RUG also were key in supporting adaptation of the 
research intervention (CSNAT- Stroke) and staff training 
package, including role- playing videos of the intervention 
in practice. A video summarising their role in OSCARSS 
is available on the study website: https://www. arc- gm. 
nihr. ac. uk/ projects/ oscarss, and following GRIPP2 
framework19 we have published a separate paper on the 
working practices and experiences of RUG members and 
the researchers who facilitated the group meetings.16
Participants
English- speaking informal carers of stroke survivors were 
eligible if they were over 18 years old and received at 
least one face- to- face support contact from participating 
cluster staff. Carers could be included at any time post- 
stroke event with any level of need or support require-
ments. We focused on those newly referred to the service 
as opposed to those using services for some time as 
core parts of the intervention included identification of 
carers. We aimed to recruit those individuals identified 
as ‘primary caregiver’, even when there may have been 
other informal carers involved.
Following the first face- to- face support contact (either 
intervention or control), eligible carers were invited 
by cluster staff to find out more about potential study 
participation and given up to 6 weeks to make a deci-
sion. Carers were assured that their decision on study 
participation would have no impact on the provision 
of ongoing support (either intervention or control). If 
carers accepted, their details were passed securely to the 
research team who provided full study information by 
post and sought informed written consent to participate. 
Procedures were also in place for consent to be taken by 
telephone. Researchers were in regular contact with all 
cluster staff and senior leadership to encourage fidelity 
with research procedures, including the consistent invita-
tion to participate for all eligible carers.
Randomisation and masking
Details of the randomisation and masking were described 
in the protocol.18 Briefly, clusters were recruited (with 
consent of senior leadership and frontline staff within 
the provider organisation) by research staff before 
randomisation to ensure allocation concealment at a 
cluster level. Clusters were block randomised to interven-
tion or control, with stratification for size of service using 
random blocks of two (to ensure similar numbers of carers 
and clusters in each arm). The trial statistician performed 
the randomisation of all recruited clusters simultaneously 
using an anonymised list of cluster ID numbers and size 
of service data. The initial randomisation list produced 
allocations for 36 clusters, with a second randomisation 
list produced to allocate up to 16 clusters in the event of 
needing to replace clusters that dropped out or failed to 
recruit.
Cluster staff could not be masked as training was 
required to equip them to participate in the study. 
Training included participant recruitment and trial proce-
dures (control and intervention arms of the trial) and the 
intervention (intervention arm only). The research team 
were masked to allocation as far as possible, although 
some team members could become unmasked during 
cluster staff training or support activities. Carer research 
participants provided self- report primary and secondary 
outcomes unaware of allocation; they received support 
from their local randomised cluster and consented to 
follow- up data collection only. Carers were told that 
the service was being evaluated but not told about the 
randomised clusters.
Interventions and procedures
The intervention is a person- centred, structured process of 
assessment and support that is practitioner facilitated, but 
carer led. It enables carers to identify and prioritise their 
unmet needs during routine support contacts by staff; 
and then collaboratively put in place tailored support to 
meet identified needs. The intervention includes: a needs 
assessment tool; an action plan; and a multistage person- 
centred framework for introducing and using them both. 
The intervention is delivered typically at home visits that 
also include stroke survivors being supported by the same 
staff member. Staff in all clusters were trained in the study 
processes but only those in intervention clusters were 
trained to implement this individualised approach, using 
instructional videos, role- play and workbooks. Implemen-
tation does not include change to local, external support 
services available to carers—although staff were encour-
aged to create service directories, in case signposting or 
referral was required. The intended intervention is illus-
trated in figure 1, summarised in table 1 which highlights 
differences to usual care and described in detail in online 
supplemental table S1, adapted Template for Interven-
tion Description and Replication checklist.20
We compared the intervention to usual care within clus-
ters (also summarised in table 1 and described in online 
supplemental table S1). Although the service delivery 
organisation had well- defined practices for supporting 
stroke survivors, support for carers was typically offered 
but variable across services.
Study entry data included demographic and clin-
ical characteristics of carers and their cared- for stroke 
4 Patchwood E, et al. BMJ Open 2021;11:e038777. doi:10.1136/bmjopen-2020-038777
Open access 
survivors, along with EQ- 5D- 5L.21 These were collected 
through carer self- report postal questionnaires at the same 
time as consent. As support (intervention or control) was 
implemented at a cluster level and designed to begin at 
the first point of contact with a carer, study entry data 
could not be considered truly ‘baseline’ as it was collected 
after support had been initiated, although data such as 
age, gender and date of stroke could be assumed to be 
constant. Initial and follow- up outcomes were sought 
by carer self- report postal questionnaire 3 and 6 months 
after support was initiated. In addition, service delivery 
records for all consented carers were extracted by the 
service provider at the end- of- study data collection.
Outcomes
Primary outcome was the strain subscale from the FACQ9 
3 months after the start of intervention. Three- month and 
6- month outcomes postal questionnaire packs were iden-
tical in content. Carers were provided with the option to 
complete them over the telephone with support from a 
researcher. Packs included:
 ► The FACQ9 with subscales for strain, distress and 
positive appraisals of the impact of caring. Each item 
was scored from 1 to 5 and each subscale produced a 
mean score out of 5, with a score of 3 as neutral, and 
higher scores indicating a greater amount of the vari-
able being measured.
 ► The Pound Carer Satisfaction with Stroke Services 
Scale,22 with higher scores indicating more satisfac-
tion with services (composite score maximum of 44; 
standalone ‘smiley faces’ overall score maximum of 
7).
 ► The Hospital Anxiety and Depression Scale23 for carer 
anxiety and depression, with higher scores indicating 
higher mood disturbance and clinical cut- offs of: non- 
cases (0–7); mild (8–10); moderate (11–14); severe 
(15–21).
 ► An adapted version of the Service Receipt Inventory11 
to collect information on carers’ use of NHS and 
social care services and the EQ- 5D- 5L21 as the measure 
of health benefit used in the economic evaluation.
Routinely collected service delivery records for 
consented carers (described in Interventions and Proce-
dures) included: the dates, types and duration of direct 
and non- direct support activities provided; standardised 
entries from staff pertaining to needs identified and 
actions taken during support contacts. Needs and action 
categories were pre- existing within the service provider 
records management system and not altered for the 
purpose of the trial.
We collected data on how often staff used the interven-
tion’s needs assessment tool and action plan but primarily 
evaluated implementation using qualitative methods in 
our separately reported process evaluation.17
No serious adverse events (SAEs) were expected to be 
related to the intervention. All known AEs were typically 
collected via outcomes postal packs or during routine 
study follow- up calls with participants or cluster staff. SAEs 
were reported if they were deemed related and unex-
pected. Protocol deviations were recorded, for example, 
return of 3- month outcome measures more than 6 weeks 
late.
Statistical and economic analysis
A full Statistical Analysis Plan was published with the study 
protocol.18 We explored a range of projected sample sizes 
in our protocol. A minimum of 400 carers recruited from 
32 clusters (200 per trial arm) would provide 80% power 
to detect standardised effect sizes on the primary outcome 
of 0.31 or more (FACQ Strain mean score), assuming an 
intraclass correlation coefficient (ICC) of 0.01 with a 20% 
loss to follow- up, at the 5% significance level. Power was 
calculated using the Stata clsampsi function.24 We did not 
expect the cluster ICC to be >0.05.25
The primary analysis was intention to treat (ITT), 
comparing intervention and control at 3 months using 
a multilevel regression model with adjustment for clus-
tering and using the following fixed individual level 
covariates: time post- stroke; age of carer; health of carer 
at study entry; stroke severity (as rated by carer); and 
the following cluster level covariates: size of service and 
experience of staff delivering support. Missing covariate 
data were imputed using multiple imputation via the ‘mi 
impute’ function in Stata. Sequential imputation using 
chained equations was used to create 10 datasets. At least 
6 of the 8 items on the primary outcome (FACQ Strain 
subscale at 3 months) had to be completed for inclu-
sion in primary analysis. Similar analysis was used for all 
numerical secondary outcome measures. Sensitivity anal-
yses were prespecified in the Statistical Analysis Plan to 
explore any potential bias and examine the robustness of 
findings.
An analysis plan for the economic evaluation was also 
published as part of the study protocol. The economic 
evaluation compared the intervention with usual care over 
the 6- month follow- up period using an ITT approach and 
from the NHS and social care perspective. The measure 
of health benefit was utility, derived from EQ- 5D- 5L at 
each assessment using the crosswalk methods as currently 
recommended by the National Institute for Health and 
Care Excellence.26 Quality- adjusted life years (QALYs) 
were calculated from these utility values using an area 
under the curve approach. The costs for the economic 
evaluation include the costs associated with NHS and 
social care resources used by carers during the study and 
the direct costs associated with delivering the interven-
tion/control. The intervention- related costs included 
training for staff and time spent providing support 
(extracted from service delivery records). Further details 
of the economic methods are reported in online supple-
mental material.
Regression models, based on multiple imputed data-
sets, were used to estimate net costs (generalised linear 
model with gamma family and log link) and QALYs 
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(linear model) for the intervention arm compared 
with the control arm. Models allowed for clustering 
by adjusting for the same cluster- level covariates as the 
clinical- effectiveness analysis (see above) and the models 
were specified so that the CIs allowed for intragroup 
correlation. Net costs were divided by net QALYs to calcu-
late an Incremental Cost- Effectiveness Ratio (ICER). The 
net costs and QALYs were bootstrapped 2000 times to esti-
mate robust 95% CIs and plotted on a cost- effectiveness 
plane. Prespecified sensitivity analyses were conducted, 
including complete case analyses.
Role of the funding source
The NIHR CLAHRC had no role in study design, data 
collection, data analysis, data interpretation or writing 
of the paper. Stroke Association partnered with NIHR 
in funding this study and was the specialist stroke service 
provider in OSCARSS. They did provide some data (eg, 
service delivery records) and contributed to discussions 
about data interpretation and dissemination of find-
ings. The corresponding author had full access to all the 
study data and had final responsibility for the decision to 
submit for publication.
RESULTS
In September 2016 we randomised 36 clusters (18 inter-
vention; 18 control). Three control and one intervention 
cluster withdrew soon after due to decommissioning or 
all staff long- term sickness (see figure 2) so 32 clusters 
were trained in January 2017. Three replacement clus-
ters were recruited, randomised and trained between 
February and April 2017 (one intervention; two control). 
This gave a total of 35 recruiting clusters (18 interven-
tion; 17 control). Cluster and staff baseline characteristics 
are included in online supplemental table S2.
Between January 2017 and July 2018, 628 eligible carers 
(334 intervention; 294 control) were referred for poten-
tial participation across 35 participating clusters (18 inter-
vention; 17 control) in England and Northern Ireland. Of 
those eligible, 414 (66%) carers consented (208 interven-
tion; 206 control) and were followed up between March 
Figure 2 CONSORT diagram showing cluster recruitment and patient flow. All numbers correspond to number of carers 
unless otherwise stated. All percentages are out of number of consented carers. *Postal packs had not been returned after 13 
weeks/21 weeks/26 weeks for demographic/3- month/6- month data. CONSORT, Consolidated Standards of Reporting Trials; 
OSCARSS, Organising Support for Carers of Stroke Survivors.
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2017 and December 2018. Participant flow is shown in 
figure 2 and consented carer study entry characteristics 
are shown in table 2.
Of the 414 consented participants, 319 (77%) were 
women and 315 (76%) were partners/spouses of the 
stroke survivor they cared for and 399 (97%) were ethni-
cally white. The mean age of carers was 62 years old when 
they joined the study and the median time from the 
stroke event to support being initiated was 2.3 months 
across the whole sample (IQR=1.1–2.3). All measured 
variables related to consented carers were well balanced 
across intervention and control groups, including the 
level of independence of the cared- for stroke survivor, as 
perceived by carers.
Primary outcomes were available for 175 (84%) of 
consented carers in the intervention group and 174 (84%) 
in the control group. Follow- up (secondary) outcomes 
were available for 124 (60%) of consented carers in the 
intervention group and 142 (69%) in the control group.
Primary analysis of all outcomes is shown in table 3. 
Clustering for the primary outcome was low (ICC=0.02) 
and negligible after adjustment for covariates. For our 
primary outcome measure we found the mean (SD) 
FACQ carer strain at 3 months to be 3.11 (0.87) in the 
control group compared with 3.03 (0.90) in the inter-
vention group, adjusted mean difference −0.04 (95% CI 
−0.20 to 0.13). Note that this CI excludes the minimal 
important difference of 0.31 used in our sample size 
calculation and therefore the data are not consistent with 
a clinically relevant difference between intervention and 
control groups. Similarly when we looked at the longer 
term FACQ carer strain at 6 months we observed a mean 
control measure of 3.10 (0.88) compared with 3.07 (0.87), 
adjusted mean difference −0.04 (95% CI −0.22 to 0.14). 
All other secondary outcome measures had small differ-
ences and tight CIs (see table 3) and therefore are not 
consistent with meaningful differences between control 
and intervention. Both unadjusted and adjusted estimates 
of intervention effect were similar, providing no evidence 
of any confounding due to demographic or clinical vari-
ables. These findings were consistent across all sensi-
tivity analyses including: excluding delayed responders; 
removing carer dyads; imputing missing outcome data; 
and combining 3- month and 6- month data, suggesting 
that the results are robust to assumptions made in the 
analysis.
The clinical interpretation of selected findings was 
that for the primary outcome, carer strain, both groups 
reported an average of around 3 out of 5 that is, a neutral 
level. For secondary outcomes, average levels of anxiety 
and depression were around 8 and 6/7 out of 21 (mild 
and non- case, respectively). Both groups tended to ‘agree’ 
with the positive appraisal of the impact of caregiving that 
is, average scores 4 out of 5. Satisfaction ratings for both 
groups were towards the higher end of the composite 
scale, an average of around 30 out of 44.
For the economic evaluation, there was a high propor-
tion of missing data but economic analysis was still 




  Male 42 (20.4) 51 (24.5)
  Female 164 (79.6) 155 (74.5)
  Missing data – 2 (1)
Age, mean (range) 62.5 (24–86) 62.3 (21–88)
Relationship with stroke survivor, n (%)
  Husband/wife or 
partner
160 (77.7) 155 (74.5)
  Parent 2 (1.0) 6 (2.9)
  Son/daughter 39 (18.9) 41 (19.7)
  Other 5 (2.5) 5 (2.5)
  Missing data – 1 (0.5)
Lives relative to stroke survivor, n (%)
  In the same household 179 (86.9) 172 (82.7)
  Within walking 
distance
8 (3.9) 12 (5.8)
  Within 30 min drive/
public transport
16 (7.8) 16 (7.7)
  More than 30 min 
drive/public transport
3 (1.5) 8 (3.8)
Marital status, n (%)
  Single 18 (9) 9 (4)
  Married/living as 
married
177 (85) 178 (87)
  Other 13 (6) 18 (8)
  Missing data 1 (0) –
Ethnicity, n (%)
  White 200 (97.1) 199 (96.7)
  Mixed/multiple ethnic 
groups
– 4 (1.9)
  Asian/Asian British 6 (2.9) 5 (2.4)
Employment status, n (%)
  Employed full- time 30 (14.6) 25 (12.0)
  Employed part- time 23 (11.2) 25 (12.0)
  Self- employed 13 (6.3) 9 (4.3)
  Retired 102 (49.5) 111 (53.4)
  Unemployed 11 (5.3) 12 (5.8)
  Full- time education – 1 (0.5)
  Other, including 
homemaker
27 (13.1) 25 (12)
Highest level of education, n (%)
  None 47 (22.8) 49 (23.6)
  Examinations at 16 72 (35.0) 75 (36.1)
  A/AS level or 
equivalent
41 (19.9) 29 (13.9)
  University 42 (20.4) 50 (24.0)
Continued
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feasible. We found similar neutral findings between 
groups in terms of health benefits (see table 4). Resource 
use is summarised in online supplemental tables S3–S8. 
Costs associated with the intervention were slightly higher 
(around £40 per person) than the control, primarily due 
to:
 ► Additional staff training required for the interven-
tion, calculated at £15 per consented carer supported 
in intervention- allocated clusters.
 ► Additional support provided to consented carers in 
intervention- allocated clusters, according to extracted 
service delivery records. Carers in intervention- 
allocated versus control- allocated clusters had 15 vs 
12 support activities recorded, on average, totalling 
4.7 hours vs 4.2 hours, respectively.
 ► Carers in intervention- allocated clusters self- reported 
accessing more primary care services, specifically 
general practice nurses.
These slightly higher costs without measurable health 
benefits over usual care suggest that the intervention 
as delivered is unlikely to be cost- effective (see table 5). 
This remained the case in all sensitivity analyses. Figure 3 
shows the cost- effectiveness plane for the primary anal-
ysis; the clustering around the vertical axis demonstrates 
that we can be relatively certain there is no additional 
health benefit from the intervention compared with the 
control group.
No SAEs were reported that were judged to be related 
to the research. There were 12 SAEs in total (seven inter-
vention; five control). Ten involved hospitalisation and 
two related to Accident and Emergency visits with possible 
long- term incapacity.
Service delivery records indicate that more carers 
received an individual case record in the intervention 
arm (92/208, 44%) than control arm (65/206, 32%); 
other carers had service delivery data captured along-
side a stroke survivor record. In addition, intervention 
arm carers versus control arm carers had more needs 
reported (146 vs 80) and more actions agreed (278 vs 
148), according to service delivery records.
Indicative findings from the quantitative data on the 
implementation of the intervention suggest the inter-
vention was not implemented as intended. Overall, 
of the 334 eligible carers referred to the study from 
intervention- allocated clusters, the CSNAT- Stroke needs 
assessment tool and action plan were recorded as used in 
278 (83%) and 121 (36%) cases, respectively. Similarly, 
for the 208/334 carers who went on to join the study from 
intervention- allocated clusters, they were used in 172 
(83%) and 66 (32%) cases, respectively.
DISCUSSION
In terms of clinical effectiveness and cost- effectiveness 
OSCARSS’ findings were conclusive. We found no mean-
ingful difference in the level of self- reported caregiver 
strain between those allocated to an adapted support 
intervention or to usual care. Findings were robust and 
consistent across all outcomes, time points and sensi-
tivity analyses. The economic evaluation demonstrated 
neutral findings on health benefits and slightly increased 
costs making the intervention unlikely to be cost- effective 
compared with usual care. There are several possible 
explanations for our neutral finding explored in detail 
below. In brief, carers in both groups received support 
from the same national service provider organisation, 
and at the primary outcome time point both groups had 
a level of strain categorised as neutral on average. Carers 
seen by intervention- allocated clusters received slightly 
more support and accessed more primary care services 
than carers in the control group. However, the interven-
tion was not fully delivered as intended.
Comparison with other studies
A review of multifaceted support interventions for 
stroke survivors and carers found no evidence of effec-
tiveness for carers’ subjective health status nor mental 
health (15 interventions, 1775 carers).14 A review of non- 
pharmacological interventions for carers of stroke survi-
vors also found no strong evidence to inform best practice 
for supporting carers (8 studies, 1007 carers).13 Recent 
important randomised trials of structured training for 
carers to provide care11 or deliver rehabilitation12 show 




  Other 1 (0.5) 2 (1.0)
  Missing data 3 (1.5) 3 (1.4)
Carer has long- term health condition, n (%)
  Yes 124 (60.2) 130 (62.5)
  No 82 (39.8) 78 (37.5)
Carer provided care to stroke survivor prior to stroke, n (%)
  Yes 81 (39.3) 79 (38.0)
  No 124 (60.2) 122 (58.7)
Cared- for stroke survivor characteristics (as reported by 
carer)
Months post- stroke (at date seen)
  Mean (SD) 5.93 (15.47) 6.46 (16.38)
  Median (IQR) 2.2 (1.1–4.6) 2.37 (1.2–4.8)
  Missing data, n (%) 3 (1.5) 8 (3.8)
Independence*
  Mean (SD) 10.99 (3.67) 11.14 (3.69)
  Median (IQR) 11 (8–14) 11 (8–14)
*Mean score for carer perceived independence calculated over 
6 domains: personal care, toilet, cooking, walking, transport 
and finances/legal issues. Each domain scored 1–3 (total max 
score=18) with low scores equating to greater independence.
Table 2 Continued
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Prior to OSCARSS there was no robust RCT evidence of 
the CSNAT, or any other approach, to guide the support 
of carers of stroke survivors. A non- randomised study 
of CSNAT with a non- stroke population concluded that 
the CSNAT was associated with small to moderate reduc-
tions in carer strain compared with pre- intervention.6 8 
Several UK studies by the CSNAT team showed similar 
outcomes and good acceptability, but also reported 
implementation challenges similar to those found in 
OSCARSS5 7 and discussed in our sister process evalua-
tion paper.17
Strengths and limitations, with consideration of clinical 
implications
To understand the clinical implications of these find-
ings, we consider the study’s strengths and limitations, 
and explore possible explanatory factors: the choice 
of comparator; intervention delivered; the timing and 
choice of outcomes and characteristics of the sample.
Features of the study design and conduct ensured good 
internal validity. For example, clusters were recruited 
prior to stratified randomisation and carer research 
participants—who completed self- reported outcome 
Table 3 Primary analysis of all outcomes
Control Intervention Difference (95% CI)





Primary outcome: FACQ carer strain at 3 months N=174 N=175 −0.04 (−0.20 to 0.13)
3.11 (0.87) 3.03 (0.90)
Secondary outcomes collected at 3 months after support initiated:
  FACQ carer distress N=173 N=176 0.04 (−0.13 to 0.21)
2.88 (0.83) 2.91 (0.85)
  FACQ positive caregiving appraisal N=175 N=176 0.05 (−0.06 to 0.17)
3.99 (0.61) 4.05 (0.54)
  Pound Satisfaction with stroke services (composite) N=177 N=171 −1.06 (−3.35 to 1.23)
31.14 (8.85) 30.51 (10.36)
  Pound overall Satisfaction with stroke services (smiley faces) N=174 N=167 0.00 (−0.30 to 0.31)
5.10 (1.51) 5.10 (1.49)
  HADS anxiety N=174 N=172 0.04 (−0.89 to 0.97)
8.34 (4.51) 8.20 (4.73)
  HADS depression N=174 N=172 −0.06 (−0.86 to 0.73)
6.30 (4.17) 6.12 (4.07)
Follow- up outcomes collected at 6 months after support initiated:
  FACQ carer strain N=140 N=121 −0.04 (−0.22 to 0.14)
3.10 (0.88) 3.07 (0.87)
  FACQ carer distress N=140 N=121 −0.03 (−0.23 to 0.16)
2.93 (0.84) 2.92 (0.84)
  FACQ positive caregiving appraisal N=140 N=121 0.12 (−0.02 to 0.26)
3.91 (0.64) 4.04 (0.54)
  Pound Satisfaction with stroke services (composite) N=136 N=121 −1.48 (−3.40 to 0.44)
32.12 (5.88) 30.58 (9.81)
  Pound overall Satisfaction with stroke services (smiley faces) N=138 N=120 −0.21 (−0.61 to 0.20)
5.17 (1.51) 4.99 (1.54)
  HADS anxiety N=141 N=123 0.13 (−0.98 to 1.23)
8.90 (4.66) 8.95 (5.10)
  HADS depression N=141 N=123 −0.43 (−1.36 to 0.51)
7.06 (4.56) 6.65 (4.06)
FACQ, Family Appraisal of Caregiving Questionnaire; HADS, Hospital Anxiety and Depression Scale.
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measures—were unaware of allocation. Cluster trials risk 
imbalance across trial groups27 but in OSCARSS, steps 
were taken to minimise this and all measured variables 
related to consented carers appeared well- balanced 
across arms. The intervention was implemented at 
cluster level and began the moment a carer came into 
contact with the service provider so it was not possible 
to explore change from baseline in individual outcomes, 
however the randomised design, coupled with balanced 
cluster and carer characteristics, helps overcome this. 
OSCARSS achieved its target, powered sample size with 
minimal missing clinical data and low attrition (16% in 
both groups) at the primary outcome time point. We have 
confidence in our findings which were consistent across 
Table 4 EQ- 5D utility values at each time point and QALYs 




Study entry utility 0.78 (0.75 to 0.81) 0.76 (0.74 to 0.79)
n=204 n=199
3- month utility 0.73 (0.71 to 0.76) 0.73 (0.70 to 0.76)
n=177 n=165
6- month utility 0.72 (0.69 to 0.75) 0.73 (0.69 to 0.76)
n=136 n=118
QALYs (over 6 
months)
0.37 (0.36 to 0.38) 0.38 (0.36 to 0.39)
n=135 n=103
Net QALYs* 0.009 (−0.016 to 0.033) n=238
Adjusted net 
QALYs†
0.004 (−0.018 to 0.026) n=227
*Unadjusted but allowing for intracluster correlation in SEs.
†Net QALYs calculated using linear regression model adjusted for 
age, time since stroke, stroke severity, whether or not the carer 
had any long- term health conditions, cluster size and years of 
experience of the cluster staff.
QALYs, quality- adjusted life years.
Table 5 Results of primary and sensitivity economic analyses comparing CSNAT intervention with usual care
  Net costs (95% CI) Net QALYs (95% CI) ICER (£/QALY)
Primary analysis
  Multiple imputed datasets 
(n=410)*
£39.05 (−69.61 to 147.71) −0.004 (−0.020 to 0.012) Intervention is dominated
Sensitivity analyses
  Complete cases (n=131) £41.24 (−29.01 to 111.49) −0.0001 (−0.026 to 0.026) Intervention is dominated
  Per- protocol analysis† 
(n=374)
£42.55 (−71.77 to 156.88) −0.0002 (−0.016 to 0.016) Intervention is dominated
  Exclude training and 
intervention costs (n=410)*
£23.33 (−98.21 to 144.87) −0.004 (−0.020 to 0.012) Intervention is dominated
Alternative outcome measure
  Net costs (95% CI) Net change (95% CI) ICER: (£/1 point 
improvement)
  FACQ strain, complete 
cases (n=139)
£57.32 (−15.77 to 130.41) −0.02 (ie, lower score in 
intervention group) (−0.30 to 0.26)
Intervention is dominated
All analyses adjusted for covariates: carer’s age, time since stroke, stroke severity, whether or not carer has long- term health conditions, 
length of experience of cluster staff, size of cluster and cluster ID.
CIs for all analyses calculated following bootstrapping: 2000 times for imputed datasets, 10 000 times for complete case datasets.
*Four participants with no baseline EQ- 5D data were excluded from the imputation, leaving 410 participants.
†Thirty- six participants in the imputed dataset excluded who violated protocol conditions (multiple carers per stroke survivor or 
questionnaires returned late).
CSNAT, Carer Support Needs Assessment Tool; FACQ, Family Appraisal of Caregiving Questionnaire; ICER, incremental cost- effectiveness 
ratio; QALYs, quality- adjusted life years.
Figure 3 Cost- effectiveness plane for primary analysis. 
The cost- effectiveness plane shows the ICER (large square) 
and 2000 bootstrapped estimates of net costs and QALYs. 
The narrow, even, horizontal spread of the points indicates 
low uncertainty regarding the indifferent health benefit. The 
broader vertical spread of the points shows that there is 
more uncertainty around the costs. ICER, incremental cost- 
effectiveness ratio; QALYs, quality- adjusted life years.
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all sensitivity analyses including for protocol deviations 
such as the late return of postal questionnaires.
The demographic profile of the sample was as expected 
for carers of stroke survivors and in keeping with other 
trials.11 However, as is so often the case in UK- based 
stroke trials, the sample lacked ethnic diversity (<3% 
non- white group). This does not reflect the diversity in 
the UK general population. Stroke trials need strategies 
to achieve equity of access, given that a large portion of 
UK stroke admissions are from Black, Asian and minority 
ethnic communities.28 We aimed to recruit the primary 
caregiver but did not collect additional data on whether 
they were caring alone or with support. All other measured 
carer variables were balanced across randomised groups.
Neutral findings must consider the context that carers 
in both groups received support, from the same stroke 
specialist provider organisation, and reported high 
satisfaction with stroke services on average. This and 
the outcomes achieved suggest it is plausible that both 
methods of support delivered in OSCARSS were benefi-
cial to carers.
We collaborated closely with our service provider to 
pragmatically tailor the intervention for implementa-
tion, which improved buy- in by the organisation and 
cluster staff. However, our data show that the interven-
tion’s assessment tool and action plan were underused. 
Implementation was explored in greater depth in the 
embedded process evaluation and is consistent with these 
quantitative indicators; namely, that the intervention as 
intended was not fully implemented.17
We have no data beyond 6 months after support had 
been initiated, and while our inclusion criteria aimed to 
recruit carers at varying stages, our sample was predomi-
nantly early post- stroke. Previous stroke research suggests 
caregivers may take months to adjust to their role as 
caregivers, become aware of and prioritise their own 
needs.29 The OSCARSS process evaluation and opinions 
of members of our study- specific carer advisory research 
group endorse this and suggest that, while informal care-
givers need support early after stroke, they may struggle 
to participate fully in a ‘carer- led’ intervention that 
encourages self- management, such as the CSNAT inter-
vention, which could have contributed to the implemen-
tation issues noted above. In addition, our relatively short 
follow- up period of 6 months may have been too early 
to detect any impact of carers in the intervention group 
receiving more support and accessing more primary 
healthcare services, as observed in our economic evalua-
tion. While our choice of primary outcome was informed 
by past research using the CSNAT intervention6 8 and the 
preferences of our service user group of stroke carers, our 
measure may not have been adequate to detect a differ-
ence in our population of stroke carers.
CONCLUSIONS
In summary, OSCARSS found that the CSNAT- Stroke 
intervention was not measurably clinically effective or 
cost- effective compared with usual care from a stroke 
specialist provider organisation, although we have 
substantial evidence that the intervention was not fully 
implemented in this pragmatic trial. OSCARSS demon-
strated that methodologically rigorous research evalu-
ations for carers of stroke survivors can be successfully 
delivered by voluntary sector organisations. However, the 
challenges of fully implementing person- centred care in 
research and service development need to be addressed 
through enhanced and ongoing staff training as well as 
organisational mechanisms to support and champion 
new approaches becoming embedded into practice. 
There remains a high priority for research to determine 
how best to support carers of stroke survivors.
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